Prevalence and prognostic significance of secondary lymphedema following breast cancer

Lymphatic Research and Biology

Volumn 9, Issue 3, 2011, Pages 135-141

  Hayes, Sandi ^a   Di Sipio, Tracey ^a   Rye, Sheree ^a   López, J Alejandro ^b,c   Saunders, Christobel ^d   Pyke, Chris ^e   Bashford, John ^f   Battistutta, Diana ^a   Newman, Beth ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c GRIFFITH UNIVERSITY   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e MATER HOSPITAL   (Australia)

^f WESLEY HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARM CIRCUMFERENCE; ARM SWELLING; ARTICLE; AUSTRALIA; BIOIMPEDANCE SPECTROSCOPY; BREAST CANCER; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LYMPHEDEMA; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; POPULATION RESEARCH; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SELF REPORT; SPECTROSCOPY;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHEDEMA; MIDDLE AGED; PREVALENCE; PROGNOSIS; RISK FACTORS; TIME FACTORS;

EID: 80955142395     PISSN: 15396851     EISSN: 15578585     Source Type: Journal    
DOI: 10.1089/lrb.2011.0007     Document Type: Article

References (27)

1. Szuba A, Rockson SG. Lymphoedema: Classification, diagnosis and therapy. Vasc Med 1998;3:145-156.
2. Australian Institute of Health and Welfare, Cancer in Australia: An overview, 2006. Vol. AIHW cat. no. CAN 32. 2007, Canberra: Australian Institute of Health and Welfare.
3. Hayes S, Rye S, Battistutta D, DiSipio T, Newman B. Upperbody morbidity following breast cancer treatment is common, may persist longer-term and adversely influences quality of life. Health Qual Life Outcomes. 2010;8:92.
4. Hayes SC, Janda M, Cornish B, Battistutta D, Newman B. Lymphoedema following breast cancer: Incidence, risk factors and effect on upper body function. J Clin Oncol 2008;26: 3536-3542.
5. Hayes SC. Review of Research Evidence on Secondary Lymphoedema: Incidence, prevention, risk factors and treatment. 2008, National Breast and Ovarian Cancer Centre. Available at: resources/SLER247-reviewofresearchevid.pdf. Last accessed 18 January 2011.
6. Rymal C. Lymphedema management in patients with lymphoma. Nurs Clin North Am 2001;36:709-734.
7. Sleeman J, Schmid A, Thiele W. Tumor lymphatics. Semin Cancer Biol 2009;19: 285-297.
8. Kohrt H, Nouri N, Nowels K, Johnson D, Holmes S, Lee P. Profile of immune cells in axillary lymph nodes predicts disease-free survival in breast cancer. PloS Med 2005;2:e284.
9. Pinzon-Charry A, Maxwell T, Lopez J. Dendritic cell dysfunction in cancer: A mechanism for immunosuppression. Immunol Cell Biol. 2005;83:451-461. (Pubitemid 41805745)
10. Mallon E, Powell S, Mortimer P, Ryan T. Evidence for altered cell-mediated immunity in postmastectomy lymphoedema. Br J Dermatol 1997;137:928-933. (Pubitemid 28011133)
11. Stewart F, Treves N. Lymphangiosarcoma in postmastectomy lymphedema; A report of six cases in elephantiasis chirurgica. Cancer 1948;1:64-81.
12. Hayes S, Rye S, Battistuta D, Newman B. Prevalence of upper-body symptoms following breast cancer and its relationship with upper-body function and lymphoedema. Lymphology 2010;43:178-187.
13. Brady M, Cella D, Mo F, Bonomi A, Tulsky D, Lloyd S, Deasy S, Cobleight M, Shiomoto G. Reliability and validity of the Functional Assessment of Cancer Therapy - Breast (FACT-B) quality of life instrument. J Clin Oncol 1997;15: 974-986. (Pubitemid 27106280)
14. Solway S, Beaton D, McConnell S, Bombardier C. The DASH Outcome Measure User's Manual, Second Edition. 2 ed. 2002, Toronto: Institute for Work and Health.
15. Ward LC. Bioelectrical impedance analysis: Proven utility in lymphoedema risk assessment and therapeutic monitoring. Lymph Res Biol 2006;4:51-56.
16. Cornish B. Bioimpedance analysis: Scientific background. Lymph Res Biol 2006;4:47-50.
17. Hayes SC, Janda M, Cornish B, Battistutta D, Newman B. Lymphoedema secondary to breast cancer: How choice of measure influences diagnosis, prevalence and identifiable risk factors. Lymphology 2008;41:18-28. (Pubitemid 351747151)
18. Clark B, Sitzia J, Harlow W. Incidence and risk of arm oedema following treatment for breast cancer: A three-year follow-up study. QJM 2005;98: 343-348. (Pubitemid 40663122)
19. Petrek JA. Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer 2001;92:1368-1377. (Pubitemid 32947819)
20. Ferrell BR, Grant M, Funk B, Otis-Green S, Gracia N. Quality of life in breast cancer. Part 1: Physical and social well-being. Cancer Nur 1997;20:398-408. (Pubitemid 27513640)
21. Pinzon-Charry A, Schmidt C, Lopez J. Dendritic cell immunotherapy for breast cancer. Expert Opin Biol Ther 2006; 6:591-604. (Pubitemid 43837186)
22. Nakamura R, Sakakibara M, Nagashima T, Sangai T, Arai M, Fujimori T, Takano S, Shida T, Nakatani Y, Miyazaki M. Accumulation of regulatory T cells in sentinel lymph nodes is a prognostic predictor in patients with node-negative breast cancer. Eur J Cancer 2009;45:2123-2131.
23. Kim R, Emi M, Tanabe K, Arihiro K. Immunobiology of the sentinel lymph node and its potential role for antitumour immunity. Lancet Oncol 2006;7:1006-1016. (Pubitemid 44804142)
24. Setiadi A, Ray N, Kohrt H, Kapelner A, Carcamo-Cavazos V, Levic E, Yadegarynia S, van der Loos C, Schwartz E, Holmes S, Lee P. Quantitative, architectural analysis of immune cell subsets in tumor-draining lymph nodes from breast cancer patients and healthy lymph nodes. PLoS One 2010;5:e12420.
25. Field T, Buist D, Doubeni C, Enger S, Fouayzi H, Hart G, Korner E, Lamerato L, Bachman D, Ellis J, Herrinton L, Hornbrook M, Krajenta R, Liu L, Yao J. Disparities and survival among breast cancer patients. J Natl Cancer Inst Monogr 2005;35:88-95.
26. Petrek JA, Heelan MC. Incidence of breast carcinoma-related lymphedema. Cancer 1998;83:2776-2781. (Pubitemid 29024266)
27. Hayes SC, Reul-Hirche H, Turner J. Exercise and secondary lymphedema: Safety, potential benefits, and research issues. Med Sci Sports Exerc 2009;41:483-489.